BIOADAPTIVES, INC. financial data

Symbol
BDPT on OTC
Location
Las Vegas, NV
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 11.5 % +361%
Quick Ratio 2.24 % +315%
Debt-to-equity -112 % -7.64%
Return On Equity 77.2 % +72.7%
Return On Assets -575 % +60.6%
Operating Margin -14.4K % -777%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 12M shares -99%
Common Stock, Shares, Outstanding 10.9M shares -99.1%
Entity Public Float 246K USD
Common Stock, Value, Issued 1.09K USD -99.1%
Weighted Average Number of Shares Outstanding, Basic 896M shares +22.7%
Weighted Average Number of Shares Outstanding, Diluted 10.2M shares +24.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 7.85K USD -60.5%
Cost of Revenue 2.94K USD -77.7%
General and Administrative Expense 851K USD +622%
Operating Income (Loss) -1.13M USD -246%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -380K USD -908%
Net Income (Loss) Attributable to Parent -1.11M USD -39%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted -0.04 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 262K USD +196%
Marketable Securities, Current 0 USD
Inventory, Net 44.2K USD
Assets, Current 109K USD +135%
Property, Plant and Equipment, Net 15.5K USD
Intangible Assets, Net (Excluding Goodwill) 18K USD
Assets 124K USD +168%
Accounts Payable, Current 3.34K USD -37.4%
Accrued Liabilities, Current 181K USD +23.9%
Liabilities, Current 1.59M USD -14.2%
Liabilities 1.59M USD -14.2%
Retained Earnings (Accumulated Deficit) -9.9M USD -12.6%
Stockholders' Equity Attributable to Parent -1.47M USD +18.8%
Liabilities and Equity 124K USD +168%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -97.9K USD -138%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Common Stock, Shares Authorized 1.25B shares 0%
Common Stock, Shares, Issued 10.9M shares -99.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 59.3K USD +35%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 719K USD +22.8%
Property, Plant and Equipment, Gross 18K USD
Deferred Tax Assets, Operating Loss Carryforwards 719K USD +22.8%
Preferred Stock, Shares Authorized 31M shares +210%
Additional Paid in Capital 8.44M USD +23%
Amortization of Intangible Assets 18K USD -38.9%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 43.1K USD -64.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%